320 filings
10-K/A
2023 FY
NAOV
NanoVibronix Inc
Annual report (amended)
26 Apr 24
4:05pm
8-K
NAOV
NanoVibronix Inc
15 Apr 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
10-K/A
2023 FY
NAOV
NanoVibronix Inc
Annual report (amended)
9 Apr 24
5:15pm
8-K
NAOV
NanoVibronix Inc
9 Apr 24
NanoVibronix Issues Letter to Stockholders
4:05pm
10-K
2023 FY
NAOV
NanoVibronix Inc
Annual report
8 Apr 24
5:30pm
NT 10-K
4rwu2jyczmebbj
1 Apr 24
Notice of late annual filing
4:30pm
8-K
6s31f1d9s2ri8
28 Mar 24
NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield
9:09am
DEFA14A
0k55dxu mnqv9xd5
17 Jan 24
Additional proxy soliciting materials
4:31pm
8-K
jpo9d
17 Jan 24
Other Events
4:30pm
8-K
388a1f17j3d4y0
11 Dec 23
Changes in Registrant's Certifying Accountant
4:30pm
8-K
fl1se
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
DEFA14A
45j0 equ25
29 Nov 23
Additional proxy soliciting materials
8:43pm
8-K
mti4 13uznfsqgywiud
28 Nov 23
NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan
9:00am
8-K
saf73gspab z7tnpi
21 Nov 23
Other Events
8:30am
8-K
46poh9
14 Nov 23
NanoVibronix Issues Letter to Shareholders
12:00am
8-K
8c0b8o2tadphak1
7 Nov 23
Receives Stocking Order from U.K. Distribution Partner in Anticipation of Increasing Demand
8:30am
8-K
2im35i5aus9hpujojxr
27 Sep 23
NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
8:00am
EFFECT
7i8mwg678cge7e5j
22 Sep 23
Notice of effectiveness
12:15am